LBF20210PG01: Difference between revisions
No edit summary |
No edit summary |
||
(11 intermediate revisions by the same user not shown) | |||
Line 6: | Line 6: | ||
|LipidBank=XPR1729 | |LipidBank=XPR1729 | ||
|LipidMaps=LMFA03010033 | |LipidMaps=LMFA03010033 | ||
|SysName=9- | |SysName=9,15-Dioxo- (cis-5,10) -prostadienoic acid | ||
|Common Name=&& | |Common Name=&&113,14-dihydro-15-keto Prostaglandin A_2&&9,15-Dioxo- (5Z,10) -prostadienoic acid&& | ||
|Source=13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, whose process is a ccelerated by the presence of albumin.[[Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933|{{RelationTable/GetFirstAuthor|Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933}}]][[Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917|{{RelationTable/GetFirstAuthor|Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917}}]] | |Source=13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, whose process is a ccelerated by the presence of albumin.[[Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933|{{RelationTable/GetFirstAuthor|Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933}}]][[Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917|{{RelationTable/GetFirstAuthor|Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917}}]] | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism= | |Metabolism= |
Latest revision as of 20:14, 2 November 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1729 |
LipidMaps | LMFA03010033 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20210PG01 |
113,14-dihydro-15-keto Prostaglandin A2 | |
---|---|
Structural Information | |
9,15-Dioxo- (cis-5,10) -prostadienoic acid | |
| |
Formula | C20H30O4 |
Exact Mass | 334.21440944799997 |
Average Mass | 334.4498 |
SMILES | C(CCC(=O)CC[C@H]([C@H]1CC=CCCCC(O)=O)C=CC(=O)1)CC |
Physicochemical Information | |
13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, whose process is a ccelerated by the presence of albumin. Granstrom_E et al. Fitzpatrick_FA et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|